Evidence map›Paper›PMID 41090760›Full record

ArticleCells2025

Conditional ATXN2L-Null in Adult Frontal Cortex CamK2a+ Neurons Does Not Cause Cell Death but Restricts Spontaneous Mobility and Affects the Alternative Splicing Pathway.

Jana Key, Luis-Enrique Almaguer-Mederos, Arvind Reddy Kandi, Meike Fellenz, Suzana Gispert, Gabriele Köpf, David Meierhofer, Thomas Deller, Georg Auburger

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jana KeyClinic of Neurology, Experimental Neurology, University Hospital, Goethe University Frankfurt, Heinrich-Hoffmann-Str. 7, 60528 Frankfurt am Main, Germany.ORCID 0009-0002-3208-1805
Luis-Enrique Almaguer-MederosClinic of Neurology, Experimental Neurology, University Hospital, Goethe University Frankfurt, Heinrich-Hoffmann-Str. 7, 60528 Frankfurt am Main, Germany.ORCID 0000-0003-0887-2359
Arvind Reddy KandiClinic of Neurology, Experimental Neurology, University Hospital, Goethe University Frankfurt, Heinrich-Hoffmann-Str. 7, 60528 Frankfurt am Main, Germany.
Meike FellenzInstitute for Clinical Neuroanatomy, Dr. Senckenberg Anatomy, Fachbereich Medizin, Goethe University Frankfurt, 60528 Frankfurt am Main, Germany.ORCID 0009-0002-9138-5542
Suzana GispertClinic of Neurology, Experimental Neurology, University Hospital, Goethe University Frankfurt, Heinrich-Hoffmann-Str. 7, 60528 Frankfurt am Main, Germany.
Gabriele KöpfClinic of Neurology, Experimental Neurology, University Hospital, Goethe University Frankfurt, Heinrich-Hoffmann-Str. 7, 60528 Frankfurt am Main, Germany.
David MeierhoferMax Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195 Berlin, Germany.ORCID 0000-0002-0170-868X
Thomas DellerInstitute for Clinical Neuroanatomy, Dr. Senckenberg Anatomy, Fachbereich Medizin, Goethe University Frankfurt, 60528 Frankfurt am Main, Germany.ORCID 0000-0002-3931-2947
Georg AuburgerClinic of Neurology, Experimental Neurology, University Hospital, Goethe University Frankfurt, Heinrich-Hoffmann-Str. 7, 60528 Frankfurt am Main, Germany.

Funding

Deutsche Forschungsgemeinschaft DFG AU96/21-1
6 · The paper itself

Abstract

The Ataxin-2-like (ATXN2L) protein is required to survive embryonic development, as documented in mice with the constitutive absence of the ATXN2L Lsm, LsmAD, and PAM2 domains due to knock-out (KO) of exons 5-8 with a frameshift. Its less abundant paralog, Ataxin-2 (ATXN2), has an extended N-terminus, where a polyglutamine domain is prone to expansions, mediating vulnerability to the polygenic adult motor neuron disease ALS (Amyotrophic Lateral Sclerosis) or causing the monogenic neurodegenerative processes of Spinocerebellar Ataxia Type 2 (SCA2), depending on larger mutation sizes. Here, we elucidated the physiological function of ATXN2L by deleting the LsmAD and PAM2 motifs via loxP-mediated KO of exons 10-17 with a frameshift. Crossing heterozygous floxed mice with constitutive Cre-deleter animals confirmed embryonic lethality among offspring. Crossing with CamK2a-CreERT2 mice and injecting tamoxifen for conditional deletion achieved chimeric ATXN2L absence in CamK2a-positive frontal cortex neurons and reduced spontaneous horizontal movement. Global proteome profiling of frontal cortex homogenate showed ATXN2L levels decreased to 75% and dysregulations enriched in the alternative splicing pathway. Nuclear proteins with Sm domains are critical to performing splicing; therefore, our data suggest that the Like-Sm (Lsm, LsmAD) domains in ATXN2L serve a role in splice regulation, despite their perinuclear location.

Indexed as

Alternative SplicingAtaxin-2Calcium-Calmodulin-Dependent Protein Kinase Type 2NeuronsAnimalsCell DeathMiceMice, KnockoutAtaxin-2Calcium-Calmodulin-Dependent Protein Kinase Type 2Camk2a protein, mouselabel-free mass spectrometryMRPL14NAA38NSUN2open field locomotionpoly(A)-binding proteinribonucleoproteinsRPS3SRSF11stress granules

Identifiers

PMID41090760
PMCPMC12524157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.